Podcast appearances and mentions of Peter Marks

Philip Clark is joined by Tech Guru Software Developer and Technology Commentator from Access Informatics, Peter Marks on Nightlife.

Tech Guru Peter Marks, software developer and technology commentator from Access Informatics joins Philip Clark on Nightlife with all the latest news and issues in technology.

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. The landscape of these industries continues to evolve with significant scientific advancements, regulatory breakthroughs, and strategic maneuvers that are reshaping drug development and patient care. One of the noteworthy developments is the U.S. FDA's recent approval of Gilead Sciences' Hepcludex (bulevirtide) for hepatitis D. This approval marks a comeback for Gilead after previous setbacks due to manufacturing and delivery issues, highlighting the critical importance of addressing regulatory feedback. It's a testament to persistence in overcoming manufacturing challenges to ensure vital therapies reach those in need. This approval signifies a milestone as it's the first FDA-approved therapy targeting chronic hepatitis D virus infection—a niche condition with limited treatment options. Similarly, Pfizer's Braftovi (encorafenib) is expanding its global reach beyond U.S. borders with regulatory approvals in the EU and Canada for colorectal cancer treatment. This broadening geographic footprint reflects a broader industry trend where companies aim to maximize the therapeutic impact of oncology drugs across diverse patient populations. Meanwhile, Astellas Pharma is navigating the looming patent cliff for its prostate cancer drug Xtandi by actively pursuing new licensing deals and implementing cost-cutting measures. This dual approach underscores a widespread industry strategy where companies balance acquisitions with operational efficiency to sustain growth. In the radiopharmaceutical sector, there's notable activity with Lantheus Holdings possibly being acquired by Curium for $7 billion. This potential deal underscores growing interest in radiopharmaceuticals due to their precision in targeting specific cancer types. Complementing this is Niowave's $75 million investment in a radiopharmaceutical isotope plant in Michigan, set to produce actinium-225 by 2028—an isotope crucial for targeted cancer therapies. Regulatory landscapes are also in flux with continued reforms at the FDA despite leadership changes. Initiatives like the Commissioner's National Priority Voucher program illustrate regulatory bodies' commitment to streamlining drug approvals and fostering innovation. On an international note, SK Bioscience is partnering with Colombia to locally produce the chickenpox vaccine Skyvaricella, enhancing vaccine accessibility through technology transfer. Similarly, Eli Lilly's acquisition spree in infectious disease research signals a robust push toward expanding its R&D pipeline for viral and bacterial pathogens. Eli Lilly has announced plans to acquire Curevo, Limmatech Biologics, and another vaccine company for up to $3.8 billion. This strategic acquisition underscores a commitment to enhancing capabilities in infectious diseases—a field that has gained focus post-COVID-19 pandemic. By integrating these companies, Eli Lilly aims to leverage their platforms and expertise for advanced therapeutic solutions against infectious diseases. In gene editing, Eli Lilly is preparing for a Phase 2 trial of a lipid-lowering gene editor from Verve Therapeutics, showing promising cholesterol reductions akin to PCSK9 inhibitors. This highlights gene editing's potential in addressing cardiovascular diseases. A significant development from Lilly's pipeline includes promising results from their base editor technology acquired through Verve Therapeutics—an exciting breakthrough suggesting substantial potential for gene-editing technologies addressing genetic disorders like high cholesterol. In oncology, AstraZeneca and Daiichi Sankyo's Datroway gained FDA approval for triple-negative breast cancer as a first-line treatment. This antibody-drug conjugate targets Trop2, demonstrating the potential of targeted therapy in difficult-to-treat cancers. Kura Oncology's combination therapy featuring darlifarnib and Krazati showed up to a 69% response rate in KRAS G12C-mutated solid tumors during Phase 1 trials, emphasizing precision medicine's potential in targeting specific genetic mutations driving cancer progression. In obesity management, Eli Lilly's retatrutide achieved Phase 3 success with bariatric surgery-like outcomes. The drug acts as a triple hormone receptor agonist, showcasing advancements in metabolic therapies targeting obesity—a condition linked with numerous comorbidities. Moderna's mFlusiva is poised for an FDA advisory committee review as an influenza preventative for older adults—an extension of Moderna's mRNA technology initially used against COVID-19. Collectively, these developments highlight an industry leveraging cutting-edge science and technology to tackle complex medical challenges. As pharmaceutical giants like Eli Lilly consolidate their positions through acquisitions and research collaborations, transformative advancements promise to reshape patient care across various therapeutic areas. These initiatives not only reflect the industry's dynamic nature but also its pivotal role in addressing unmet medical needs worldwide. Eli Lilly's recent strategic acquisitions underscore its commitment to advancing pharmaceutical innovations, particularly in vaccines and cholesterol management sectors. Acquiring three vaccine-focused biotech firms signifies substantial investment in expanding its vaccine portfolio—a move aligned with global immunization strategies. This follows hiring Peter Marks from the FDA, indicating a strategic focus on bolstering expertise within the vaccine domain. The company has been recognized by IDEA Pharma as a leader in pharmaceutical innovation—a testament to its robust pipeline and successful integration of scientific advancements into marketable therapies. Across oncology landscapes highlighted at ASCO conferences are exciting potentials like Summit Therapeutics and Akeso's potential Keytruda rivals that could reshape cancer treatment paradigms if proven effective. As pharmaceutical landscapes continue evolving rapidly through scientific strides tempered by regulatory hurdles—the current environment promises significant advancements offering new hope while demanding strategic agility within healthcare sectors globally.Support the show

Jonathan Howard and Wendy Orent call this week their "Red Wedding": within days, FDA Commissioner Marty Makary resigned, Vinay Prasad was pushed out of CBER, Tracy Beth Hoeg was fired, and Senator Bill Cassidy lost his Louisiana primary. The hosts argue this is not a tragedy but a long-foretold collapse — a group of physicians who built careers as COVID-era contrarian podcasters discovering that running a regulatory agency is fundamentally different from posting about one. Howard works through the wreckage: Makary's reported approval of flavored nicotine products days before his ouster, the FDA's treatment of the rare disease community, the leaked memo claiming pediatric COVID vaccine deaths that career staff refused to sign off on, and the broader pattern of "regulatory whiplash" that drove the agency into dysfunction. The episode then turns to who is still standing — Jay Bhattacharya at NIH, Robert F. Kennedy Jr. at HHS — and what Kennedy is reportedly doing to vaccines from behind the scenes via Martin Kulldorff's review effort. Throughout, the hosts return to a single thesis: the skills that made Makary, Prasad, Hoeg, and Cassidy famous during COVID — opinion, tweeting, posturing — do not translate into running institutions, and the medical commentators who vouched for them (John Mandrola, Adam Cifu) have lost any remaining credibility. Key Topics Discussed Bill Cassidy's primary loss and the cost of the Kennedy confirmation vote Cassidy's earlier vote to convict Trump after January 6 followed by his decisive vote advancing RFK Jr. as HHS Secretary. Howard and Orent's view that Cassidy's promise to "keep Kennedy in line" was hollow from the start. What Cassidy's defeat signals about Trump's grip on the Republican base in Louisiana — and the hosts' read that his lame-duck status may give him cover to block the next round of HHS nominees. Marty Makary's resignation and the "worst FDA Commissioner in 25 years" framing The Stat News piece characterizing Makary's tenure, and the reporting that flavored nicotine was the precipitating issue with Trump's tobacco-industry donors. Howard's counterpoint: Makary reportedly approved a batch of electronic nicotine delivery systems (ENDS) on May 5, 2026 — the weekend before he resigned — undercutting the "principled stand" narrative. The pattern of selfie videos, public-facing performance, and what former FDA staff describe as hostile management of career scientists. Makary's pre-FDA record: the "medical error is the third leading cause of death" claim, Omicron as "nature's vaccine," "Omicold," herd immunity calls in May 2021, and the Nazi-bioweapon Lyme disease theory amplification. Vinay Prasad, regulatory whiplash, and the rare disease community How Prasad's stated preference for randomized controlled trials translated into rejection of rare disease therapies — and the disconnect between calling for RCTs on Twitter and the practical impossibility of running them for small patient populations. Right-to-try advocates, the libertarian wing of MAHA (Senator Ron Johnson), and why they turned on Prasad. Howard's point: Pfizer's halted COVID vaccine RCT in 50–65-year-olds is the case study — the trials Prasad demanded couldn't actually be enrolled. Tracy Beth Hoeg, the leaked pediatric deaths memo, and the Maryanne Demasi interview Hoeg's insistence she was fired, not resigned, and her interview with Brownstone Institute–adjacent journalist Maryanne Demasi. Her claim that the chaos at the FDA was "created by the media" rather than real. The memo alleging 10 pediatric deaths from the COVID vaccine that career FDA staff would not sign off on — and Howard's contrast with the J&J/thrombosis response, where nine deaths produced immediate, transparent action. Hoeg's role in the Denmark-style vaccine schedule rollback memo alongside Makary. The Makary–Prasad ZDoggMD clip on FDA "vindictiveness" — and the irony Audio pulled from a pre-appointment Prasad/Makary appearance describing the FDA as "erratic," "capricious," and politically pressured. Howard's read: every criticism they leveled at the Biden-era FDA describes their own tenure — political pressure from Trump, demoted career staff, inconsistent standards. The Peter Marks / Marion Gruber / Phil Krause booster episode reframed in light of what followed. John Mandrola, Adam Cifu, and the cost of vouching Mandrola's "Can We Give the New FDA's Leadership a Chance?" piece a year earlier — and the line about Prasad and Makary inducing companies to run proper RCTs, set against Pfizer's halted trial. Howard's account of an email exchange with Cifu following Cifu's visit to NYU — Howard's offer of a serious content-level conversation, and Cifu's decline. The broader "medical conservatives" project and what the hosts argue has happened to its credibility. Jay Bhattacharya, NIH, and the resignation letter from departing staff The letter from a senior NIH scientist on Bhattacharya's leadership — political termination of grants, deals institutions are making to recover funding, and Bhattacharya's silence. Howard and Orent's read on Bhattacharya's visible deterioration and his retreat into Great Barrington nostalgia. Kennedy's behind-the-scenes vaccine review and Martin Kulldorff The New York Times reporting (Christina Jewett and Sheryl Gay Stolberg) on Kennedy's vaccine inquiry being led by Kulldorff. Howard's pushback on the framing of Kulldorff as merely "a critic of restrictions and mandates" — and the 2020 record of his herd-immunity-through-infection advocacy, including his Stockholm "almost at herd immunity" claim in April 2020. The hosts' concern that the COVID amnesia project lets pandemic-era pro-infection figures re-enter regulatory power with their record sanitized. Casey Means, Surgeon General nomination withdrawal, and MAHA fracturing The withdrawn Surgeon General nomination and what it signals. The Robert Malone vs. Makary public falling-out over the unreleased pediatric deaths data. Why the MAHA coalition — held together by shared COVID grievance — is coming apart now that COVID has receded from headlines. Notable Moments On Cassidy: "He betrayed his oath as a physician, he betrayed the American people, and he's going down into the ignominious dust." — Wendy Orent On the Makary–Prasad–Hoeg trio: "The same skill sets that catapulted these guys to power — essentially being excellent podcasters — do not translate into leading a government agency of tens of thousands of employees that regulates 20 percent of the US economy." — Jonathan Howard On the legacy: "These guys are now cautionary tales for medical students. I would love to teach a course called 'Be the Opposite of Bill Cassidy, Marty Makary, Vinay Prasad, and Tracy Beth Hoeg.'" — Jonathan Howard On Bhattacharya: "His soul has been totally corrupted by the people who he teamed up with. You also see it in his face. He's not the same person that took the position." — Jonathan Howard References Mentioned in the Episode Stat News — "Why Marty Makary Was the Worst FDA Commissioner in 25 Years" Vinay Prasad's 2016 Stat News rebuttal of Makary's "medical error" claim David Gorski (Science-Based Medicine, 2016) — rebuttal of the medical-error-as-third-leading-cause-of-death claim Jonathan Howard, Science-Based Medicine — recent piece compiling Makary's COVID-era statements New York Times — Christina Jewett and Sheryl Gay Stolberg on Kennedy's vaccine inquiry Washington Post — "Ouster of RFK's Allies Tests MAHA-Trump Alliance" Ben Mazer, The Atlantic — on whether Makary and Prasad enacted lasting change Francis Lee — In COVID's Wake Alfred Crosby — America's Forgotten Pandemic Maryanne Demasi interview with Tracy Beth Hoeg MedPage Today — Makary and Prasad, "The Importance of Humility in Medicine" People Referenced Marty Makary — outgoing FDA Commissioner Vinay Prasad — former CBER Director Tracy Beth Hoeg — fired FDA official Senator Bill Cassidy (R-LA) — lost primary Robert F. Kennedy Jr. — HHS Secretary Jay Bhattacharya — NIH Director Martin Kulldorff — leading Kennedy's vaccine review Peter Marks — former CBER Director, Operation Warp Speed Bob Kadlec — Operation Warp Speed David Kessler — former FDA Commissioner (referenced) Marion Gruber and Phil Krause — former FDA vaccine reviewers John Mandrola and Adam Cifu — "medical conservative" commentators Robert Malone — anti-vaccine activist Casey Means — withdrawn Surgeon General nominee Senator Ron Johnson (R-WI) Representative Jake Auchincloss — opened FDA whistleblower line Art Caplan — bioethicist (retirement) Erica Schwartz — CDC Director nominee, unconfirmed  

Google's annual developer "I/O" event is on this week with rumours there will be new technologies to change the way we use the internet. 

In Jim's hands today is a Press Release from the office of Senator Ron Johnson of Wisconsin. Senator Johnson is chairman of the Permanent Subcommittee on Investigations. Last Wednesday he held a hearing titled, "Unmasked: How Biden Health Officials Purposely Turned a Blind Eye Toward COVID-19 Vaccine Safety Signals." It's a hearing that drew little media attention. Along with this hearing, Senator Johnson released a report of approximately 600 pages of records that detailed how beginning in early 2021, FDA officials became aware of a new "state of the art" data mining method that could better detect statistically significant safety signals for adverse events associated with the COVID-19 shots. Rather than adopt this method, Biden health officials continued to employ their older data mining method with known limitations that prevented the FDA from detecting adverse events. Senator Johnson indicates that Peter Marks, head of the FDA's Center for Biologics Evaluation and Research, was treating vaccine injuries that were life-threatening and people were pleading with the FDA and NIH to make this pubic, but never did so. Senator Johnson indicated, "We've got a real big problem in this country about vaccine-injury deniers." Again, these vaccine injuries are real, but it's being denied. While this hearing was far longer than a Crosstalk program, listen to Senator Johnson's opening remarks, Ranking Member Senator Blumenthal, the lead Democrat of the Committee, and the witnesses.

In Jim's hands today is a Press Release from the office of Senator Ron Johnson of Wisconsin. Senator Johnson is chairman of the Permanent Subcommittee on Investigations. Last Wednesday he held a hearing titled, "Unmasked: How Biden Health Officials Purposely Turned a Blind Eye Toward COVID-19 Vaccine Safety Signals." It's a hearing that drew little media attention. Along with this hearing, Senator Johnson released a report of approximately 600 pages of records that detailed how beginning in early 2021, FDA officials became aware of a new "state of the art" data mining method that could better detect statistically significant safety signals for adverse events associated with the COVID-19 shots. Rather than adopt this method, Biden health officials continued to employ their older data mining method with known limitations that prevented the FDA from detecting adverse events. Senator Johnson indicates that Peter Marks, head of the FDA's Center for Biologics Evaluation and Research, was treating vaccine injuries that were life-threatening and people were pleading with the FDA and NIH to make this pubic, but never did so. Senator Johnson indicated, "We've got a real big problem in this country about vaccine-injury deniers." Again, these vaccine injuries are real, but it's being denied. While this hearing was far longer than a Crosstalk program, listen to Senator Johnson's opening remarks, Ranking Member Senator Blumenthal, the lead Democrat of the Committee, and the witnesses.

Peter Marks, mobile software developer and technology commentator from Access Informatics joined Philip Clark on Nightlife with the latest in Tech News.

Apple is most known for premium technology products. Premium phones, premium tablets and computers. Their phone sold so well it dominates in price-sensitive markets. 

Philip Clark is joined by Nightlife Tech Guru Peter Marks bring listeners up to speed with the latest from the world of tech, and where we are headed with the future of AI. 

Peter Marks, mobile software developer and technology commentator from Access Informatics, joined Philip Clark and listeners to Nightlife with the latest tech news.

Peter Marks, mobile software developer and technology commentator from Access Informatics, joined Philip Clark and listeners to Nightlife with the latest tech news.

Peter Marks, mobile software developer and technology commentator from Access Informatics joined Philip Clark and listeners to Nightlife with the latest tech news.

Peter Marks, software developer and technology commentator from Access Informatics joined Nic Healey on Nightlife to look back at the biggest tech stories from 2025. From the rise and rise of AI to some of the biggest challenges faced by major stakeholders in the tech world.

Echo Garden - December 2025 Mix by Peter Marks

Peter Marks, mobile software developer and technology commentator from Access Informatics, joined Philip Clark and listeners to Nightlife.

In March 2022, Dr. Joseph Fraiman taped an internal call between FDA directors and physicians who were concerned about mRNA side effects in their patients – including the cardiac arrest and sudden death of a 7-year-old days after being injected with Pfizer's mRNA vaccine. “This was a top level meeting of directors,” Dr. Fraiman revealed to Ask Dr. Drew in Sept 2023. “This entire meeting terrified my entire work group.” The call – legally recorded by Dr. Fraiman – included FDA Director Dr. Peter Marks, Dr. Peter Doshi, Dr. Celia Witten, Dr. Sarah Walinsky, Dr. Lorrie McNeill, and many other experts. “What they're saying here is they're not doing statistical testing on adverse events. This is really insane to me,” Dr. Fraiman continued. “You know there's a problem if the vaccine group has a higher rate of them.” Dr. Joseph Fraiman, MD is an emergency physician and clinical researcher focused on harm-benefit analysis. He served as Medical Manager of Louisiana's Urban Search Rescue Disaster Task Force 1 and is lead author of a widely known re-analysis of mRNA vaccine serious harms. Follow at https://x.com/josephfraiman Dr. Stephanie Venn-Watson is Co-CEO and Co-Founder of Seraphina Therapeutics. She is a veterinary epidemiologist and author of “The Longevity Nutrient” (March 2025). Her background includes DARPA, the U.S. Navy Marine Mammal Program, and research on nutritional C15:0 deficiencies. Learn more at https://drdrew.com/fatty15 「 SUPPORT OUR SPONSORS 」 • AUGUSTA PRECIOUS METALS – Thousands of Americans are moving portions of their retirement into physical gold & silver. Learn more in this 3-minute report from our friends at Augusta Precious Metals: ⁠⁠⁠⁠https://drdrew.com/gold⁠⁠⁠⁠ or text DREW to 35052 ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠• FATTY15 – The future of essential fatty acids is here! Strengthen your cells against age-related breakdown with Fatty15. Get 15% off a 90-day Starter Kit Subscription at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://drdrew.com/fatty15⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • PALEOVALLEY - "Paleovalley has a wide variety of extraordinary products that are both healthful and delicious,” says Dr. Drew. "I am a huge fan of this brand and know you'll love it too!” Get 15% off your first order at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://drdrew.com/paleovalley⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • VSHREDMD – Formulated by Dr. Drew: The Science of Cellular Health + World-Class Training Programs, Premium Content, and 1-1 Training with Certified V Shred Coaches! More at https://drdrew.com/vshredmd • THE WELLNESS COMPANY - Counteract harmful spike proteins with TWC's Signature Series Spike Support Formula containing nattokinase and selenium. Learn more about TWC's supplements at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twc.health/drew⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ 「 ABOUT THE SHOW 」 Ask Dr. Drew is produced by Kaleb Nation (⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://kalebnation.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠) and Susan Pinsky (⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twitter.com/firstladyoflov⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠e⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠). This show is for entertainment and/or informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment. Executive Producers • Kaleb Nation - ⁠⁠⁠⁠⁠⁠⁠⁠https://kalebnation.com⁠⁠⁠⁠⁠⁠⁠⁠ • Susan Pinsky - ⁠⁠⁠⁠⁠⁠⁠⁠https://x.com/firstladyoflove⁠⁠⁠⁠⁠⁠⁠⁠ Content Producer & Booking • Emily Barsh - ⁠⁠⁠⁠⁠⁠⁠⁠https://x.com/emilytvproducer⁠⁠⁠⁠⁠⁠⁠⁠ Hosted By • Dr. Drew Pinsky - ⁠⁠⁠⁠⁠⁠⁠⁠https://x.com/drdrew⁠⁠⁠⁠⁠⁠⁠⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

Peter Marks, mobile software developer and technology commentator from Access Informatics, joined Philip Clark and listeners to Nightlife. 

Echo Garden - November 2025 Mix by Peter Marks

Peter Marks, mobile software developer and technology commentator from Access Informatics, joined Philip Clark and listeners to Nightlife.

To close out this season of the pod, Abdul and Katelyn record from the American Public Health Association's annual convention. They discuss the current public health landscape, as the government shutdown threatens SNAP and WIC funding. Then, they are joined by Dr. Peter Marks, the former director of the FDA's Center for Biologics Evaluation and Research. They discuss the future of public health, and the road ahead. America Dissected is taking an indefinite pause. We thank you for six amazing years.  Check out our shop at store.americadissected.com for our America Dissected merch – including logo shirts, hoodies and mugs. And don't miss our “Vaccines Work. Science Matters.” t-shirts! This show would not be possible without the generous support of our sponsors. America Dissected invites you to check them out. This episode was brought to you by: Quince: Go to Quince.com/AD for free shipping on your order and 365-day returns. Now also available in Canada.ExpressVPN: Secure your online data today by visiting ExpressVPN.com/Dissected to find out how you can get up to four extra months FREE.

Peter Marks, mobile software developer and technology commentator from Access Informatics, joined Philip Clark and listeners to Nightlife with a comprehensive discussion. 

Peter Marks, mobile software developer and technology commentator from Access Informatics, joined Philip Clark and listeners to Nightlife with a comprehensive discussion. 

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Zenas has made a $2 billion bet on autoimmune diseases with Chinese firm InnoCare, focusing on the development of orelabrutinib for multiple sclerosis. Former FDA director Peter Marks has joined Eli Lilly, marking the company's continued push in China. Sanofi's advancements in radiopharma, Boehringer Ingelheim's breakthrough in idiopathic pulmonary fibrosis, and Takeda's exit from cell therapy are also top stories. Cytiva filtration is highlighted as a solution for maintaining product integrity in biopharma.Biospace profiles the five most powerful women leading smaller biopharmaceutical companies, as the industry sees a shift with the departure of GSK CEO Emma Walmsley. A survey by CRB reveals that most life sciences companies are not planning new investments after tariffs, with big pharma taking the lead in manufacturing initiatives. Drug pricing criticism often overlooks the dynamic nature of drug pricing over time. Takeda's journey in building a cell therapy portfolio, only to ultimately walk away, is explored. Pfizer wins the bid for Metsera, Amgen offers Repatha at a discounted rate, and Roche acquires Akero for $3.5 billion. Biospace also honors 40 under 40 winners making an impact in the industry.Peter Marks, former director of the FDA's Center for Biologics Evaluation and Research, has taken on a new role as Senior Vice President for molecule discovery and the head of infectious diseases at Eli Lilly. Marks' controversial exit from the FDA led to his hiring by Lilly, following in the footsteps of another former FDA official, Rachael Anatol. Marks confirmed his new role to Stat News and began his first day at Lilly Research Laboratories on Monday.Support the show

Peter Marks, mobile software developer and technology commentator from Access Informatics, joined Philip Clark and listeners to Nightlife with a comprehensive discussion.

Peter Marks, mobile software developer and technology commentator from Access Informatics joined Philip Clark and listeners to Nightlife with a comprehensive discussion about mobile phones.

Peter Marks is a software developer and technology commentator from Access Informatics, joined Philip Clark on Nightlife to discuss the latest tech news. 

Peter Marks, software developer and technology commentator from Access Informatics, joined Philip Clark on Nightlife to discuss the latest news in technology. 

What if you could ask your angels and guides any question? Tune in for an inspiring discussion with Psychic Medium Peter Marks & Ken Elliott as we discuss their new show Creating Heaven on Earth: Conversations with the Angels and Guides. Moments with Marianne airs in the Southern California area on KMET1490AM & 98.1 FM, an ABC Talk News Radio Affiliate!  https://www.kmet1490am.comPeter Marks is an internationally respected psychic medium, astrologer, and spiritual life coach who prefers to be called a “spirit guide.” Known for his rare ability to connect with God's universe and deliver clear, specific messages from those who have passed, Peter offers guidance that brings peace, clarity, and transformation. For more than 25 years, he has provided personal readings for clients around the world, including celebrities and royalty, and has been a sought-after guest on radio and television programs. https://www.petermarkspsychic.com Ken Elliott is a nationally recognized artist, author, and manifesting mentor. In his book Manifesting 123 and You Don't Need #3, Ken reveals a simple, proven process to turn thoughts into reality — no special skills required. Filled with true stories and practical tools, this guide can help you create the life you want and stop empowering negative thoughts. Find the book and learn more at www.Manifesting123.comAsk a question to the angels & guides for an upcoming show: https://www.petermarkspsychic.com/questionsSchedule an appointment with Peter Marks: https://www.petermarkspsychic.com/sessionsSchedule a manifesting appointment with Ken Elliott:  https://manifesting123.com/sessions/For more show information visit: https://www.mariannepestana.com/

Peter Marks, software developer and technology commentator from Access Informatics, joined Philip Clark on Nightlife to discuss the latest news in technology.

Savitri D and Reverend Billy in a broad ranging conversation with Indigenous activist and artist Leonard Peltier. You can learn more about Leonard Peltier and see his art HERE This episode of Earth Riot Radio premiered Aug 9 on WBAI 99.5 FM Radio For The People in New York City. Thanks to Charris Ford and Peter Marks. Special editing by Debbie Daughtry

@petermarks on the main stage of @canyonvibration opening for @djdissolve and @aguycalledgerald. Feel free to comment for a track id!

Peter Marks, software developer and technology commentator from Access Informatics, joined Philip Clark on Nightlife to discuss the latest news in technology.

Peter Marks is the former director of the FDA Center for Biologics Evaluation and Research. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. P. Marks. The Role of Public Health Agencies in Creating Vaccine Policy. N Engl J Med 2025;393:209-211.

The FBI arrests alleged child predators. The Food and Drug Administration (FDA) hires a new top vaccine official to replace Dr. Peter Marks. And the Department of Government Efficiency's (DOGE) effort has hit a new milestone, as well as a new legal snag. Let's go through a full update on today's episode of Facts Matter.Episode Resources:

Doctors announced this week that they have treated a newborn baby with a rare genetic disease using the world’s first personalized gene editing therapy. Geoff Bennett discussed the treatment and its potential with Dr. Peter Marks. He oversaw gene therapy treatment and vaccine safety and approval for the FDA before he left in March. PBS News is supported by - https://www.pbs.org/newshour/about/funders

America Out Loud PULSE with Dr. Vaughn & Dr. Tankersley – If the news is accurate that the nominee for Surgeon General, Casey Means, is pregnant, I hope she avoids the COVID shot for her child and tells the world why. The new FDA vaccine director, Dr. Vinay Prasad, replaces the fraudulent Peter Marks and is immediately called an ‘anti-vaxxer' despite decades of giving them to his patients...

Nurses Out Loud – No press conference. No accountability. Just a quiet exit from the man who greenlit experimental technology injected into hundreds of millions of Americans, including children. But this resignation isn't just about one man. It's about a system that shields itself from responsibility while silencing dissent. Dr. Peter Marks wasn't simply a figurehead...

Del recaps ICAN's explosive D.C. press conference exposing former FDA official Dr. Peter Marks for blocking recognition and support for the COVID-19 vaccine injured. Jefferey Jaxen reports on the health freedom movement sweeping U.S. states, a perplexing power outage in Spain and Portugal, and new fertility concerns tied to the COVID shot. Del is joined by John Miller to preview the 2025 Food Independence Summit: Seed to Spoon, celebrating America's growing self-sufficiency movement.Guest: John MillerBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.

Filmmakers Mikki Willis and Matt Guthrie open up about the making of Follow the Silenced—a bold new documentary that gives voice to those vaccine-injured and silenced during the COVID era. Featuring exclusive recorded calls with FDA's Dr. Peter Marks and CDC officials, the film reveals the hidden cost of government censorship. After fleeing California amid backlash, the filmmakers returned for a triumphant Hollywood premiere—where the film took home “Best of Fest” and “Best Director” at the Santa Monica Film Festival.Become a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.

Megyn Kelly is joined by FDA Commissioner Dr. Marty Makary for his first interview in his new position to discuss what he's learned since taking over the position 17 days ago, whether there are people in the building who are open to MAHA, what's currently working properly at the agency and what's not, the issues with the VAERS system, recent critiques from Peter Marks who left the agency, the need to ask questions in science and not jump to conclusions, his new policy limiting who can serve as members on FDA advisory committees, his efforts to counter the perception that the FDA has been captured by Big Pharma and other industries, how he learned first-hand about "the swamp," the apolitical work he and RFK are doing, his efforts to get certain drugs approved faster and to limit animal testing, the truth about the DOGE cuts and how no scientists or reviewers were cut, his relationship with RFK, his effort to redo the food pyramid, the efforts by RFK to get to the cause of autism, the need to look at environmental and dietary exposures that could alter the microbiome, and more. Grand Canyon University: https://GCU.eduLean: Visit https://TakeLean.com & use code MK20 for 20% offAncient Nutrition: Enjoy 25% off your first order at https://AncientNutrition.com/MEGYNFollow The Megyn Kelly Show on all social platforms:YouTube: https://www.youtube.com/MegynKellyTwitter: http://Twitter.com/MegynKellyShowInstagram: http://Instagram.com/MegynKellyShowFacebook: http://Facebook.com/MegynKellyShow Find out more information at: https://www.devilmaycaremedia.com/megynkellyshow

First, from pesticide lawsuits to mRNA vaccine bans, Jefferey Jaxen breaks down major health freedom battles across the U.S. and abroad; Aaron Siri, Esq. & React19's Brianne Dressen expose new legal action against AstraZeneca; Filmmakers Mikki Willis & Matthew Guthrie reveal the truth behind Follow the Silenced; EXCLUSIVE: Secret recordings of Dr. Peter Marks admitting vaccine harm behind closed doors.PLUS: A shocking virtual timeline drops soon, featuring never-before-seen FDA docs and footage from the COVID-19 vaccine rollout.Visit TheRealPeterMarks.comPress conference + full timeline release: April 16, 2025#TheHighWire #ICAN #FollowTheSilenced #PeterMarks #VaccineInjuries #HealthFreedomGuests: Brianne Dressen, Aaron Siri, Esq., Matt Guthrie, Mikki WillisBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.

Measles is an extremely contagious disease. It's also extremely preventable. There's a vaccine. It's highly effective. For decades it has made measles outbreaks in the U.S. relatively rare, and measles deaths rarer still. But the U.S. has now seen more than 700 measles cases this year, and 3 deaths so far with active outbreaks across six states.The federal response is under scrutiny because Health and Human Services Secretary, Robert F. Kennedy, Jr. has made a career spreading false information about vaccines.What are this administration's views on vaccines, and what do they mean for what is already one of the worst U.S. measles outbreaks this century. Kennedy publicly promised he would support vaccines. Dr. Peter Marks, who was forced out as the nation's top vaccine regulator says his department isn't doing enough.For sponsor-free episodes of Consider This, sign up for Consider This+ via Apple Podcasts or at plus.npr.org.Email us at considerthis@npr.org.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

An extended version of Margaret Brennan's full interview with Dr. Peter Marks, the former head of FDA's Center for Biologics Evaluation and Research, a portion of which aired on "Face the Nation with Margaret Brennan" on April 13, 2025.  To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

This week on Face the Nation, President Trump's multi-front trade war whipsaws markets, and China fires back. What's next as the world's two biggest economic powers clash? Despite backing off of what he called "reciprocal tariffs" against dozens of countries, and announcing new exemptions on some key consumer products, the president is digging in on tariffs against China. We discuss what's next with U.S. Trade Representative Jamieson Greer. Then, we get a read on the broader economic impact from the president of the Federal Reserve Bank of Minneapolis, Neel Kashkari. Silicon Valley's Democratic Congressman Ro Khanna also joins us with reaction from the tech sector. Plus , we  have a new poll on how Americans think Trump is handling the economy. And finally, an update on the measles outbreak with the former top vaccine regulator with the FDA, Dr. Peter Marks. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

About this episode: Last week, the Department of Health and Human Services abruptly fired around 10,000 employees, 3,500 of which were within the FDA alone—an organization of around 18,000 total employees as of January 2025. In this episode: A look at the work of the FDA and how it may be hampered by such significant cuts, and how patients may be among those most impacted. Guest: Dr. Robert Califf served as the FDA Commissioner under Presidents Barack Obama and Joe Biden. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Dr. Peter Marks's Resignation Letter (PDF)—The New York Times Widespread firings start at federal health agencies including many in leadership—NPR Shots The U.S. Food Safety System—Public Health On Call (June 2022) FDA Commissioner Dr. Robert Califf on Bivalent COVID-19 Vaccines, Combating Misinformation, and Building Trust—Public Health On Call (August 2022) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

America Out Loud PULSE with Dr. Vaughn & Dr. Tankersley – Dr. Peter Marks, longtime FDA vaccine chief, is out—sparking scrutiny over his role in pushing COVID shots despite safety concerns. Billionaire doctor Patrick Soon-Shiong joins critics, calling for a return to honest medicine. From vaccine mandates to ignored cancer breakthroughs, this exposé reveals the deep flaws and corruption driving today's medical-industrial complex. Truth must come first.

Mike & Nick on the student visas that have been revoked by the State Department across the country, a look at some of these stories, writer Ken Reid joins to discuss his recent article on two other instances where this took place under other U.S. Presidents, plus, who is Dr. Peter Marks and why is his resignation important. This episode is brought to you by - Fresh Roasted Coffee - Have a cup of the best tasting coffee that gets Mike & Nick through breaking down the latest in news & politics!  Visit our link - https://lddy.no/1hvgr & use our promo code CANWEPLEASEGET20 for 20% off your first purchase.And by SeatGeek.  NBA, NHL, MLB, concerts, you name it, SeatGeek has the tickets! Go to seatgeek.com or download the SeatGeek app and use our promo code CANWEPLEASETALK at checkout to get $20 off that ticket purchase!Support this show http://supporter.acast.com/can-we-please-talk. Become a member at https://plus.acast.com/s/can-we-please-talk. Hosted on Acast. See acast.com/privacy for more information.

Peter Marks' resignation from the FDA, pushed by RFK Jr., is a win for those who believe in accountability and transparency in government agencies. Marks played a key role in the rushed approval of COVID-19 vaccines, prioritizing Big Pharma’s interests over the American people's right to informed consent and medical freedom. His departure signals a much-needed shake-up in the bureaucratic machine that has long operated without oversight, rubber-stamping experimental treatments while silencing dissent. This is a victory against government overreach and corporate collusion, proving that public pressure can still hold unelected officials accountable. The Wellness Company prides itself on pushing back against censorship and tyranny. It's why it has developed a series of prescription drug medical emergency kits that prescribed directly to you and delivered to your door to use incase of an emergency. You will have on hand much needed antibiotics, antivirals and antiparasitics, including Ivermectin. Please visit TWC.Health/Grant and use the promo code "Grant" for 10% off. See omnystudio.com/listener for privacy information.

The FDA’s top vaccine official has resigned. On Friday, Dr. Peter Marks wrote that Health Secretary Robert F. Kennedy Jr. wants “subservient confirmation of his misinformation and lies.” That follows this week’s announcement that the Department of Health and Human Services would fire around 10,000 of its workers. Ali Rogin speaks with two former HHS leaders about what this means for the country. PBS News is supported by - https://www.pbs.org/newshour/about/funders